Instilación intrapleural de activador tisular de plasminógeno y de deoxirribonucleasa recombinante humana en el empiema pleural. Visits. Download PDF. Se colocó un catéter en el extremo aórtico de la fístula y se instauró, a su través, tratamiento con activador recombinante tisular del plasminógeno (r-TPA) en. activator in vascular warning syndromesTrombólisis intravenosa con activador tisular del plasminógeno recombinante en los síndromes de alarma vascular☆.

Author: Daikasa Faebei
Country: Azerbaijan
Language: English (Spanish)
Genre: Business
Published (Last): 15 February 2009
Pages: 61
PDF File Size: 17.7 Mb
ePub File Size: 3.52 Mb
ISBN: 149-7-41056-906-4
Downloads: 9017
Price: Free* [*Free Regsitration Required]
Uploader: Arashinris

Si continua navegando, consideramos que acepta su uso. SRJ is a prestige metric based on the idea that not all citations are the same.

SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.

To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. The aim plasminogebo this study is to describe the response and complications related to the use of rTPA in the management of life- threatening cardiac thrombi in newborns.


There was a problem providing the content you requested

Nine issues are published each year, including mostly originals, reviews and consensus documents. CiteScore measures average citations received per document published. There were no deaths or embolism. Continuing navigation will be considered as acceptance of this use.

Activador del plasminógeno tisular recombinante en el manejo de trombos cardiacos en recién nacidos

Previous article Next article. The patients included 4 males with a mean weight of gr. This item has received. They received between 1 to 5 cycles with rTPA. From Monday to Friday from 9 a. Subscribe to our Newsletter. The medical records of 8 newborn were reviewed in a retrospective study, of whom 7 were preterm with cardiac thrombi, and rTPA was used in all of them. Are you a health professional able to prescribe or dispense drugs?

Thrombolysis with recombinant tissue plasminogen activator rTPA has been used as an alternative to heparin in life threatening giant thrombus and embolization.

Print Send to a friend Export reference Mendeley Statistics. Intracardiac thrombi; Neonatal thrombolysis; Recombinant tissue plasminogen activator. The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years. Recombinant tissue plasminogen activator for the management of intracardiac thrombi in newborns.


SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field. You can change the settings or obtain more information by clicking here. Three patients received low molecular weight heparin xctivador to using rTPA.

The journal fully endorses the goals of updating knowledge and plasminogenoo the acquisition of key developments in internal medicine applied to clinical practice.

Four patients had intracranial haemorrhage grade I, without sequelae at follow-up. The superior vena cava was the most frequent location, with a mean time of installation before the diagnosis of 12 days.

Subscriber If you already have your login data, please click here. March Pages ee24 Pages The incidence of cardiac thrombi in newborns has increased with the use recombniante central venous catheters. In 4 patients complete resolution of the thrombus was achieved in a mean of 3.